Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology)
- PMID: 5430156
Item in Clipboard
Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology)
Rev Eur Etud Clin Biol.
1970 May.
No abstract available
Similar articles
-
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumors.Cancer Res. 1978 May;38(5):1465-7. Cancer Res. 1978. PMID: 580415
-
Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them.Biomedicine. 1974 Mar 20;21(3):101-6. Biomedicine. 1974. PMID: 4429763 No abstract available.
-
Methoxy-9-ellipticine. II. Analysis in vitro of the mechanism of action.Rev Eur Etud Clin Biol. 1970 May;15(5):539-41. Rev Eur Etud Clin Biol. 1970. PMID: 5430157 No abstract available.
-
Biochemical aspects of drug combinations.Cancer Chemother Rep 2. 1974 Mar;4(1):115-29. Cancer Chemother Rep 2. 1974. PMID: 4135108 Review. No abstract available.
-
A modified screening system to select new cytostatic drugs.Behring Inst Mitt. 1984 May;(74):301-28. Behring Inst Mitt. 1984. PMID: 6383326 Review. No abstract available.
Cited by
-
New cancer chemotherapy drugs in Europe.Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141. Cancer Chemother Pharmacol. 1978. PMID: 373907 Review. No abstract available.